6533b870fe1ef96bd12cf1ad

RESEARCH PRODUCT

Atrial fibrillation in highly trained endurance athletes — Description of a syndrome

Gianfranco CervellinEnrique Serrano-ostárizFabian Sanchis-gomarRoman LeischikCarme Perez-quilisHerbert LöllgenAlejandro LuciaGiuseppe Lippi

subject

Malemedicine.medical_specialtyExercise Endurance Arrhythmias Fibrosis Remodeling Left atriumEnfermedad cardiovascularLeft atriumArritmia030204 cardiovascular system & hematologyArrhythmiasEndurance03 medical and health sciencesSex Factors0302 clinical medicineHeart arrhythmiaRisk FactorsSex factorsEndurance trainingAtrial FibrillationmedicineHumans030212 general & internal medicineExerciseParoxysmal AFSistema cardiovascularVentricular RemodelingbiologyAthletesbusiness.industryAge FactorsAtrial fibrillationSyndromemedicine.diseasebiology.organism_classificationFibrosisRemodelingmedicine.anatomical_structureAthletesLeft atriumPhysical EndurancePhysical therapyCorazón - EnfermedadesFemaleCardiology and Cardiovascular Medicinebusinesshuman activitiesHeart damage

description

Atrial fibrillation (AF) is the most common heart arrhythmia, the risk of which typically increases with age. This condition is commonly associated with major cardiovascular diseases and structural heart damage, while it is rarely observed in healthy young people. However, increasing evidence indicates that paroxysmal AF can also onset in young or middle-aged and otherwise healthy endurance athletes (e.g., cyclists, runners and cross-country skiers). Here we review the topic of AF associated with strenuous endurance exercise (SEE), for example cycling, running and cross-country skiing, especially at a competitive level, and we propose the definition of a new syndrome based on the accumulating data in the literature: SEE-related AF under the acronym of ‘PAFIYAMA’ (‘paroxysmal AF in young and middle-aged athletes’). Special emphasis is given to the proper differentiation of PAFIYAMA from ‘classical AF’ regarding pathophysiology, diagnosis and medical management. Sin financiación 4.034 JCR (2017) Q2, 41/128 Cardiac and Cardiovascular Systems 1.200 SJR (2017) Q1, 78/369 Cardiology and Cardiovascular Medicine No data IDR 2017 UEM

10.1016/j.ijcard.2016.10.047http://hdl.handle.net/11562/950378